Novo Integrated Sciences, Inc.

NVOS · OTC
Analyze with AI
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Activities
Net Income-$13,269-$13,269-$33,045-$4,471
Dep. & Amort.$2,303$2,303$3,019$1,724
Deferred Tax$0$0$16,382$77
Stock-Based Comp.$0$385$427$155
Change in WC-$1,202$461-$823-$29
Other Non-Cash$9,926$7,877$8,156$1,518
Operating Cash Flow-$2,243-$2,243-$5,884-$1,025
Investing Activities
PP&E Inv.-$49-$49-$190-$256
Net Acquisitions$0$0$57$3,728
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$296-$473
Investing Cash Flow-$49-$49$163$2,999
Financing Activities
Debt Repay.$4,751-$1,571-$444-$2,776
Stock Issued$240$1,795$0$7,328
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4,227$540$17-$234
Financing Cash Flow$764$764-$427$4,317
Forex Effect-$234-$234$33-$66
Net Chg. in Cash-$1,762-$1,762-$6,114$6,225
Supplemental Information
Beg. Cash$2,179$2,179$8,293$2,068
End Cash$416$416$2,179$8,293
Free Cash Flow-$2,293-$2,293-$6,074-$1,281
Novo Integrated Sciences, Inc. (NVOS) Financial Statements & Key Stats | AlphaPilot